EGFR and metastatic neoplasm: In serum, EGFR mRNA levels were found to decline significantly following surgical resection in 56 patients with early stage NSCLC (Zhuo et al., 2014).In our patients, although serum EGFR mRNA declined in patients with metastatic as well as non-metastatic disease, the degree of decline was similar between both groups.